Related Experiment Video
Updated: Mar 9, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Thrombocytopenia: A Destruction of Platelets
1Family Nurse Practitioner, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas. Edythe M. Greenberg, PhD, RN, FNP-BC, is a family nurse practitioner who has worked with the Department of Leukemia at the University of Texas MD Anderson Cancer Center for 10 years. Dr. Greenberg also has previous nursing experience in nursing education, emergency health, and family health.
Platelets are vital blood cell fragments for hemostasis. This review covers causes and treatments for thrombocytopenia, a condition of low platelet counts that increases hemorrhage risk.
Area of Science:
- Hematology
- Cell Biology
Background:
- Platelets, or megakaryocytes, are essential blood cell fragments crucial for hemostasis.
- Disorders characterized by low platelet counts, known as thrombocytopenia, significantly elevate the risk of bleeding complications.
Purpose of the Study:
- To provide a comprehensive overview of the diverse etiologies underlying thrombocytopenia.
- To discuss current therapeutic strategies for managing patients with low platelet counts.
Main Methods:
- Literature review of scientific articles and clinical studies on platelet disorders.
- Synthesis of information regarding the causes and management of thrombocytopenia.
Main Results:
- Identified numerous causes contributing to the development of thrombocytopenia.
- Summarized established and emerging treatment options for various forms of low platelet count disorders.
Conclusions:
- Understanding the etiology of thrombocytopenia is critical for effective patient management.
- Current therapies offer various approaches to address low platelet counts and mitigate bleeding risks.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis